Psychedelics News

Press Releases from Psychedelics Companies

Newsroom

Psychedelics news releases from psychedelics companies published by Newsfile. Searches will return results from stories up to two years old.

Neural Announces Approval of the Strategic Investment and Option Agreement by CWE Shareholders to Acquire up to 100% of CWE
Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's leading...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-07-22 7:30 AM EDT | Neural Therapeutics Inc.
Neural Advances Ethnobotanical Strategy Through Execution of SERFOR Research Agreement and CWE's Exclusive German Distribution Agreement with Ritual Herbs
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce two major developments that strengthen its ethnobotanical strategy: (i)...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-07-21 8:53 AM EDT | Neural Therapeutics Inc.
Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of GMP-grade MDMA and natural psilocybin, is pleased to announce that it has entered into subscription agreements pursuant to which it proposes...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-07-18 7:00 AM EDT | Optimi Health Corp.
Telescope Innovations Presents Results of Third Fiscal Quarter 2025
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2025 (Q3). The Company...
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-07-16 3:00 PM EDT | Telescope Innovations Corp.
Red Light Holland Announces Bitcoin Balance Sheet Strategy and Names Scott Melker as Lead Cryptocurrency Advisor
Toronto, Ontario--(Newsfile Corp. - July 15, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-15 8:03 AM EDT | Red Light Holland Corp.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company's Netherlands Facility via USA Controlled Substances Permit
Groundbreaking and major precedent setting milestone as first global shipment, via USA Controlled Substances import permit, of naturally occurring Psilocybin from Red Light Holland's facility in Europe successfully delivered to the Company's Partner FDA-Compliant and DEA-Registered Irvine Labs in CaliforniaPsilocybin potency testing and implementation of advanced shelf life extension protocols...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-14 7:45 AM EDT | Red Light Holland Corp.
Steep Hill Terminates SPA with Lir Life Sciences Inc.
Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") announces that further to its press release of February 12, 2025, the Company has terminated: the (i) share purchase agreement (the "Original Purchase Agreement"), dated as of February 12, 2025, (ii) first amending...
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-03 5:00 PM EDT | Steep Hill Inc.
Red Light Holland Announces Dr. Robin Carhart-Harris as Scientific Advisor
Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-02 8:12 AM EDT | Red Light Holland Corp.
HealingMaps and Advanced Behavioral Strategies Launch Healing Health Alliance, the First Group Purchasing Organization (GPO) Exclusively for Ketamine, Psychedelic Medicine and TMS Clinics
Miami, Florida--(Newsfile Corp. - July 1, 2025) - HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and TMS clinics, and Advanced Behavioral Strategies (ABS), a JV between HealingMaps and Capstone Management Group, today announced the official launch of the Healing Health Alliance, the first-of-its-kind Group Purchasing Organization (GPO) dedicated...
Multimedia/Internet/Online Services, Publishing/Informational Services, Health, Psychedelics
2025-07-01 9:00 AM EDT | HealingMaps Inc.
Red Light Holland Partners with Arizona State University to Support Groundbreaking Psychedelic Genome Project (PGP) Research Study
Toronto, Ontario--(Newsfile Corp. - June 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-06-19 8:05 AM EDT | Red Light Holland Corp.
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Denver, Colorado--(Newsfile Corp. - June 18, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that Psychedelic Science 2025 ("PS2025") - the world's largest international gathering focused on psychedelic research, biopharma, medicine, policy, and culture, hosted by the Multidisciplinary Associ
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-18 8:30 AM EDT | Psyence Biomedical Ltd.
Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements
New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal notification from the Nasdaq Hearings Panel confirming that the Company has regained compliance with all applicable Nasdaq continued listing requirements. This confirmation follows...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-17 8:00 AM EDT | Psyence Biomedical Ltd.
PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors
Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing that Rob Steen has resigned as...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-06-16 9:04 AM EDT | PharmaDrug Inc.
Aion Therapeutic Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company's audit committee and board of directors approved a change in the Company's auditors from DNTW Toronto LLP (the "Former Auditor") to Horizon Assurance LLP (the "Successor Auditor"),...
Cannabis, Psychedelics, Cannabis Extractor, Cannabis Ancillary Service Provider
2025-06-06 5:38 PM EDT | Aion Therapeutic Inc.
PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing that the board of directors ("the...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-06-06 8:00 AM EDT | PharmaDrug Inc.
Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-06 7:30 AM EDT | Neural Therapeutics Inc.
Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine
Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - June 2, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo," or the "Company") is pleased to announce a proposed name change to "Born Defense" and a change of business to become an investment issuer focused on the defense and national security space guided...
Health, Psychedelics
2025-06-02 6:11 AM EDT | Silo Wellness Inc.
Neural Therapeutics and Hanf.com Sign Strategic Investment and Option Agreement to Create a Science-Backed Botanical Wellness Leader
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, a leading German CBD retailer,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-28 1:52 PM EDT | Neural Therapeutics Inc.
Psyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical Trial
New York, New York--(Newsfile Corp. - May 27, 2025) - Psyence BioMed (NASDAQ: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company developing nature-derived psilocybin therapies for unmet mental health needs, today announced the finalization of its service agreement with Southern Star Research Pty Ltd ("Southern Star Research"), an award-winning,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-27 7:30 AM EDT | Psyence Biomedical Ltd.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles
Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the Company's farm in The Netherlands to the United States, via a Controlled Substances Import Permit.Following this major milestone approval, Red Light Holland will ship their carefully packaged raw psilocybin truffles...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-05-21 8:18 AM EDT | Red Light Holland Corp.

Have you heard? TMX Group has acquired Newsfile

Psychedelics News

Press Releases from Psychedelics Companies

Newsroom

RSS Feeds

Tell your psychedelics story, report your results

Cookie Settings

Have you heard? TMX Group has acquired Newsfile

Tell your psychedelics story, report your results